Seattle's Parse Biosciences lands another legal victory in patent dispute
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Yahoo Finance6d
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
Coupled with the invalidation of 10x Genomics’ 10,155,981 patent last ... Chief Executive Officer of Parse Biosciences. "Parse offers a fundamentally differentiated solution that makes single ...
10x Genomics price target lowered to $18 from $19 at Barclays
Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
Business Wire6d
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of ... issued Final Written Decisions invalidating all claims in 10x Genomics’ 10,697,013 and 10,240,197 patents.
Mena FN7d
Parse Biosciences Invalidates All 10X Genomics' Patent Claims Asserted Against Its Products
(BUSINESS WIRE )--Parse Biosciences , a leading provider of ... issued Final Written Decisions invalidating all claims in 10x Genomics' 10,697,013 and 10,240,197 patents. Coupled with the ...
Business Wire5d
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
Parse Biosciences, a leading provider of accessible ... issued Final Written Decisions invalidating all claims in 10x Genomics’ 10,697,013 and 10,240,197 patents. Coupled with the invalidation ...